Find an Alzheimer's clinical trial

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Search title, drug, condition or sponsor

Recruiting

Exact registry status

Phase

Intervention class

Study type

Country

Results per page

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,951–6,975 of 7,816 matching trials · page 279 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial	Phase	Status	Enrolled	Sponsor	Last updated
Pharmacokinetic Interaction Between AZD3480 and Donepezil NCT00713765 AZD3480; Donepezil Runs in: United Kingdom · 1 site	PHASE1 symptomatic-cholinergic	TERMINATED	33	AstraZeneca INDUSTRY	2014-08-15
Escitalopram for the Treatment of Depression in Alzheimer's Disease NCT01841125 escitalopram; Placebo Runs in: South Korea · 1 site	PHASE4 other	COMPLETED	84	Konkuk University Medical Center OTHER	2014-08-13
Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease NCT01849042 Ebixa; donepezil Runs in: South Korea · 1 site	PHASE4 symptomatic-cholinergic	UNKNOWN	188	Konkuk University Medical Center OTHER	2014-08-13
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease NCT00476008 Memantine; Placebo Runs in: United States · 1 site	PHASE4 symptomatic-cholinergic	COMPLETED	60	Florida Atlantic University OTHER	2014-08-11
A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia NCT01276353 E2020; E2020 Runs in: Japan · 11 sites	PHASE2 other	COMPLETED	45	Eisai Inc. INDUSTRY	2014-08-08
Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults NCT01609335 F-18 FDG; C-11 PiB Runs in: United States · 1 site	PHASE1 other	COMPLETED	41	Mayo Clinic OTHER	2014-08-08
Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness NCT02212119 Botulinum Toxin; Saline Runs in: Canada · 1 site	PHASE2 other	COMPLETED	10	Assistive Technology Clinic, Canada OTHER	2014-08-08
Promoting Informed Decision Making Through Advance Care Planning NCT02211287 'Comfort Care at the End of Life for Persons with Dementia'; Projec... Runs in: United Kingdom · 1 site	NA other	UNKNOWN	420	Queen's University, Belfast OTHER	2014-08-07
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease NCT01399125 Rivastigmine Patch; Rivastigmine Capsules; Placebo to Rivastigmine ... Runs in: China · 16 sites	PHASE3 symptomatic-cholinergic	COMPLETED	501	Novartis Pharmaceuticals INDUSTRY	2014-08-04
Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly NCT01661894 BrainPalTM Runs in: Singapore · 1 site	PHASE1 other	COMPLETED	82	Duke-NUS Graduate Medical School OTHER	2014-07-25
Occupational Therapy Programme of Patients With Dementia Performing Activities of Daily Living NCT02199353 Stimulation of Activities Daily Living; Conventional ADLOccupationa... Runs in: Spain · 1 site	NA other	COMPLETED	58	University of Extremadura OTHER	2014-07-25
Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers NCT00750282 Florbetaben (BAY94-9172) Runs in: Australia; Germany; Japan; Switzerland; United States · 23 sites	PHASE2 other	COMPLETED	422	Lantheus Biosciences Ltd. INDUSTRY	2014-07-24
Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease NCT01492374 BMS-241027; BMS-241027; BMS-241027; Placebo matching BMS-241027 Runs in: Canada; France; Germany; Sweden; United States · 24 sites	PHASE1 other	COMPLETED	40	Bristol-Myers Squibb INDUSTRY	2014-07-24
Oxaloacetate Pharmacokinetics and Safety NCT02063308 Oxaloacetate (OAA) Runs in: United States · 1 site	NA other	COMPLETED	6	Russell Swerdlow, MD OTHER	2014-07-24
Quality Improving Program on Agitation in the Surgical Intensive Care Unit NCT02199262 music intervention; reflexology; reminder Runs in: Switzerland · 1 site	NA other	COMPLETED	1,107	University Hospital, Geneva OTHER	2014-07-24
Pilot Study of Cognitive Assessment in Welsh Speakers NCT02199782 Welsh language Cognitive Assessment Runs in: United Kingdom · 1 site	NA other	UNKNOWN	100	Conor Martin OTHER_GOV	2014-07-24
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease NCT00235716 dl-alpha-tocopherol; Memantine; dl-alpha-tocopherol; Memantine; Placebo Runs in: Puerto Rico; United States · 14 sites	PHASE3 symptomatic-cholinergic	COMPLETED	613	US Department of Veterans Affairs OTHER_GOV	2014-07-23
Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease NCT00501111 AZD3480; Donepezil Runs in: Austria; Belgium; Bulgaria; Canada; Czechia; Germany; Rom... · 70 sites	PHASE2 symptomatic-cholinergic	COMPLETED	659	AstraZeneca INDUSTRY	2014-07-23
Physical Activity Training Program for Patients With Alzheimer's Dementia NCT02196545 Exercise Runs in: Germany · 1 site	NA other	COMPLETED	30	Technische Universität Dresden OTHER	2014-07-22
The Talking Sense Communication Programme for Dementia Carers NCT01481363 The Talking Sense manual; Treatment as usual - communication inform... Runs in: United Kingdom · 1 site	PHASE1\|PHASE2 other	COMPLETED	55	University of Portsmouth OTHER	2014-07-21
Effects of Exercise on Cognitive Performance of Patients With Alzheimer-type Dementia. Pilot Study. NCT02195596 High intensity aerobic exercise+strength; Low intensity aerobic exe... Runs in: Spain · 3 sites	NA other	UNKNOWN	80	Basque Health Service OTHER_GOV	2014-07-21
Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning NCT01193816 loxapine; Placebo Runs in: France · 1 site	PHASE4 other	COMPLETED	100	Assistance Publique - Hôpitaux de Paris OTHER	2014-07-18
Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers NCT00403520 Experimental 1; Placebo Comparator Runs in: France · 1 site	PHASE4 symptomatic-cholinergic	COMPLETED	240	Eisai Inc. INDUSTRY	2014-07-14
Hormone and Information Processing Study NCT00539305 testosterone gel; placebo gel Runs in: United States · 1 site	PHASE3 other	COMPLETED	22	University of Washington OTHER	2014-07-14
Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease NCT00478205 Aricept (donepezil SR 23 mg); Aricept (donepezil IR 10 mg) Runs in: United States · 1 site	PHASE3 symptomatic-cholinergic	COMPLETED	1,467	Eisai Inc. INDUSTRY	2014-07-11

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry: ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file: 7,816
Source file: trials.csv (3.8 MB, 7816 rows)
Basis: Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024 · score 88/100
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial The Lancet. Neurology, 2026 · score 86/100
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2021 · score 86/100
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease Journal of Alzheimer's disease : JAD, 2026 · score 86/100
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial EBioMedicine, 2024 · score 85/100

All 162 studies on Clinical trials →